SCHEMBL196008

SCHEMBL196008

c1ccc2cc(-c3ccc4ccccc4c3-c3ccc4ccccc4c3)ccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.53
GPR84 Q9NQS5 1/20 0.50
HDAC4 P56524 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
DNMT1 P26358 1/20 0.44
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
CYP1A2 P05177 3/20 0.43
ALOX5 P09917 2/20 0.43
MAPT P10636 1/20 0.42
TSHR P16473 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HSD17B10 Q99714 2/20 0.42
CYP2A6 P11509 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
DHFR P00374 1/20 0.42
HIF1A Q16665 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenanthrene SCHEMBL25209335 0.98 GSTP1 (0.52) GSTP1GPR84HDAC4HDAC2HDAC8
SCHEMBL4262940 0.87 CYP2A6 (0.43) GSTP1GPR84HDAC4HDAC2HDAC8
SCHEMBL27923117 0.87 GPR84 (0.48) GSTP1GPR84HDAC4HDAC2HDAC8
SCHEMBL28387886 0.87 HDAC4 (0.49) GSTP1GPR84HDAC4HDAC2HDAC8
SCHEMBL57186 0.86 GSTP1 (0.52) GSTP1GPR84HDAC4HDAC2HDAC8
SCHEMBL28086807 0.85 GSTP1 (0.47) GSTP1GPR84HDAC4HDAC2HDAC8
SCHEMBL3193310 0.85 GSTP1 (0.64) GSTP1GPR84HDAC4HDAC2HDAC8
SCHEMBL24377038 0.85 CYP1A1 (0.44) GSTP1GPR84HDAC4HDAC2HDAC8
SCHEMBL24377132 0.85 GPR84 (0.46) GSTP1GPR84HDAC4HDAC2HDAC8
SCHEMBL22414169 0.85 SMN1; SMN2 (0.46) GSTP1GPR84HDAC4HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 487 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3262055-B1 WATER SOLUBLE FLUORESCENT OR COLORED DYES COMPRISING CONJUGATING GROUPS SONY GROUP CORP (JP) 2026-04-22 EP claimed
EP-4137818-B1 USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS SONY GROUP CORP (JP) 2025-12-10 EP claimed
EP-4590341-A1 POLYMERS WITH DUAL THERAPEUTIC AGENTS Sony Group Corporation (JP) 2025-07-30 EP claimed
EP-4590340-A1 POLYMERS WITH STEROIDS OR VITAMINS Sony Group Corporation (JP) 2025-07-30 EP claimed
EP-3440136-B1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS SONY GROUP CORP (JP) 2025-07-23 EP claimed
US-12359071-B2 Polymeric tandem dyes with linker groups Sony Group Corporation (JP) 2025-07-15 US claimed
WO-2025047293-A1 COMPOUND, DETECTION SYSTEM, AND MEASUREMENT DEVICE ソニーグループ株式会社 2025-03-06 WO claimed
US-20250009898-A1 PYRROLOBENZODIAZEPINE CONJUGATES FOR CANCER TREATMENT SONY GROUP CORP (JP) 2025-01-09 US claimed
US-20250009786-A1 AUTOMATED SYNTHESIS OF POLYMERIC DUAL DRUGS Sony Group Corporation (JP) 2025-01-09 US claimed
US-20240294767-A1 POLYMERIC TANDEM DYES WITH LINKER GROUPS SONY GROUP CORP (JP) 2024-09-05 US claimed
WO-2017214165-A1 IONIC POLYMERS COMPRISING FLUORESCENT OR COLORED REPORTER GROUPS SONY CORPORATION (JP) 2017-12-14 WO claimed
WO-2017196954-A1 ULTRA BRIGHT POLYMERIC DYES WITH PEPTIDE BACKBONES SONY CORPORATION (JP) 2017-11-16 WO claimed
WO-2017197144-A1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES SONY CORPORATION (JP) 2017-11-16 WO claimed
WO-2017177065-A2 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS SONY CORPORATION (JP) 2017-10-12 WO claimed
WO-2017173348-A1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH RIGID SPACING GROUPS SONY CORPORATION (JP) 2017-10-05 WO claimed
WO-2017173355-A1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES SONY CORPORATION (JP) 2017-10-05 WO claimed
WO-2016183185-A1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES SONY CORPORATION (JP) 2016-11-17 WO claimed
US-7423133-B2 Fluorescent glycosides and methods for their use THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2008-09-09 US claimed
US-20040215012-A1 FLUORESCENT GLYCOSIDES AND METHODS FOR THEIR USE THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2004-10-28 US claimed
WO-2004019002-A2 FLUORESCENT GLYCOSIDES AND METHODS FOR THEIR USE THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2004-03-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12359071-B2 Polymeric tandem dyes with linker groups CHRM1, IK, TMT1A GSTP1 2365/4885GPR84 3222/4885HDAC4 2520/4885
US-20250009898-A1 PYRROLOBENZODIAZEPINE CONJUGATES FOR CANCER TREATMENT CHRM1, TPD52L2, H1-3 GSTP1 1669/4885GPR84 2268/4885HDAC4 1024/4885
US-20250009786-A1 AUTOMATED SYNTHESIS OF POLYMERIC DUAL DRUGS CHRM1, CHRM2, H1-0 GSTP1 1860/4885GPR84 3899/4885HDAC4 3856/4885
US-20240294767-A1 POLYMERIC TANDEM DYES WITH LINKER GROUPS CHRM1, IK, TMT1A GSTP1 2365/4885GPR84 3222/4885HDAC4 2520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.